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Introduction:  Dopamine D3 receptors (D3Rs) are G-protein-coupled receptors.  These 
D3Rs inhibit adenylyl cyclase and the downstream formation of cAMP.  Due to their 
preferential expression in the mesolimbic areas, especially in the nucleus accumbens 
(NAc), they are known to play a major role in the mesolimbic function.  Recently, we 
found that D3Rs are phosphorylated at serine 229 (Ser229) by Ca2+/calmodulin-
dependent protein kinase II (CaMKII)1.  This phosphorylation is subject to the 
modulation, and the phosphorylation level controls receptor function.  In this study, an 
effort was made to develop a phospho- and site-specific antibody.  Using this antibody, 
we hypothesized that the modulation of D3R phosphorylation at Ser229 by dopamine 
D1 receptors would occur in the mouse NAc in vivo. 
Methods:  To detect phosphorylation of D3Rs at Ser229 in striatal neurons in vivo, we 
developed a phospho- and site-specific antibody.  A short peptide containing phospho-
Ser229 (KRILTRQNpSQCISI) was synthesized and used as an immunogen for 
producing a polyclonal antibody from rabbits.  Upon demonstration of the selectivity of 
this antibody, we used it in Western blot to monitor changes in Ser229 phosphorylation 
in striatal neurons in response to dopamine D1 receptor stimulation by a D1 selective 
agonist SKF81297.  Following IACUC approval, adult male mice (CL57/BL6) were 
randomly divided into 2 groups (n = 3 per group).  The animals received an 
intraperitoneal injection of saline or SKF81297 (1 mg/kg).  Animals were sacrificed by 
cervical dislocation 15 min after drug injection.  The NAc was removed and 
homogenized.  Homogenates were centrifuged (1000 g, 10 min), and the supernatant 
was used for Western blot.  Densities of immunoblots were measured using optical 
scanning and the data were analyzed using Student's t-test (p < 0.05). 
Results:  A series of control experiments validated the selectivity of the antibody 
against phosphorylated D3Rs at Ser229 (pD3R-Ser229).  Using this antibody, we found 
that the level of pD3R-Ser229 in the NAc was significantly increased in mice treated 
with a systemic injection of the D1 receptor agonist SKF81297 (1 mg/kg, 15 min) 
compared to mice treated with saline. 
Conclusion:  Using a phospho- and site-specific antibody against phospho-D3Rs at 
Ser229, we found that stimulation of dopamine D1 receptors increases phosphorylation 
of D3Rs in the mouse NAc in vivo. 
Discussion:  Developing a phospho- and site-specific antibody is necessary for 
detecting changes in D3R phosphorylation in vivo. Using this newly acquired antibody, 
we found that Ser229 phosphorylation of D3Rs is subject to the modulation by 
dopamine D1 receptors.  This seems to indicate a previously-unrecognized D1-
dependent negative feedback control of D3R function given that Ser229 
phosphorylation inhibits D3Rs1.  In a subpopulation of striatal neurons that co-express 
D3Rs and D1 receptors, dopamine is able to concurrently enhance the D1-mediated 
phosphorylation of D3Rs to induce a heterologous desensitization of D3Rs after their 
activation.  This regulation is deemed important for maintaining normal homeostasis of 
D3R function and could be altered to contribute to various neurological disorders. 
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